7Baggers
 published on: 2025-11-16 01:31:17  newser.com Sun, 16 Nov 2025 07:31:17 GMT
 Published on: 2025-11-16 00:33:42  newser.com Sun, 16 Nov 2025 06:33:42 GMT
 Lyell Immunopharma COO Hill sells $1.5k in shares By Investing.com  Investing.com Nigeria Thu, 13 Nov 2025 20:35:31 GMT
 Lyell Immunopharma CEO Seely sells $6637 in stock By Investing.com  Investing.com Nigeria Thu, 13 Nov 2025 11:30:16 GMT
 Lyell Immunopharma: Q3 Earnings Snapshot  New Haven Register Thu, 13 Nov 2025 09:42:35 GMT
 Lyell Immunopharma VP sells $3847 in stock By Investing.com  Investing.com Australia Thu, 13 Nov 2025 08:00:00 GMT
 Lyell Immunopharma Reports Q3 2025 Financial Results  TipRanks Thu, 13 Nov 2025 04:12:33 GMT
 Lyell Immunopharma CSO sells $2230 in shares By Investing.com  Investing.com Nigeria Thu, 13 Nov 2025 02:26:09 GMT
 Lyell Immunopharma CSO sells $2230 in shares  Investing.com India Thu, 13 Nov 2025 02:05:03 GMT
 Lyell Immunopharma VP sells $3847 in stock  Investing.com India Thu, 13 Nov 2025 02:05:02 GMT
 Lyell Immunopharma: Q3 Earnings Snapshot  San Francisco Chronicle Wed, 12 Nov 2025 23:15:19 GMT
 Lyell Immunopharma reports Q3 revenue $15k vs $34k last year  TipRanks Wed, 12 Nov 2025 21:51:03 GMT
 Lyell Immunopharma Q3 adjusted net loss beats estimates  MarketScreener Wed, 12 Nov 2025 21:41:37 GMT
 Lyell boosts pipeline with acquisition of novel CAR T therapy  The Pharma Letter Wed, 12 Nov 2025 17:48:47 GMT
 Lyell acquires worldwide rights from ICT to CAR T-cell therapy  Pharmaceutical Technology Tue, 11 Nov 2025 13:42:52 GMT
 Lyell acquires global rights to colorectal cancer CAR T-cell therapy  Investing.com Nigeria Tue, 11 Nov 2025 06:51:54 GMT
 Lyell Immunopharma acquires exclusive global rights to LYL273  TipRanks Tue, 11 Nov 2025 02:57:55 GMT
 lyell acquires global rights to colorectal cancer car t-cell therapy by investing.com  Investing.com South Africa Mon, 10 Nov 2025 13:08:05 GMT
 Lyell Immunopharma Secures Global Rights for LYL273  TipRanks Mon, 10 Nov 2025 13:05:30 GMT
 published on: 2025-11-10 01:37:00  newser.com Mon, 10 Nov 2025 07:37:00 GMT
 published on: 2025-11-06 12:44:09  newser.com Thu, 06 Nov 2025 18:44:09 GMT
 published on: 2025-11-04 03:36:30  newser.com Tue, 04 Nov 2025 09:36:30 GMT
 lyell’s dual-targeting car t-cell therapy shows promise in lymphoma  Investing.com India Tue, 04 Nov 2025 05:05:56 GMT
 Lyell Immunopharma Appoints New Financial Leadership Team  TipRanks Mon, 03 Nov 2025 08:00:00 GMT
 Lyell’s dual-targeting CAR T-cell therapy shows promise in lymphoma  Investing.com Mon, 03 Nov 2025 08:00:00 GMT
 published on: 2025-10-31 03:26:35  newser.com Fri, 31 Oct 2025 08:26:35 GMT
 published on: 2025-10-30 06:17:45  newser.com Thu, 30 Oct 2025 11:17:45 GMT
 published on: 2025-10-30 02:39:25  newser.com Thu, 30 Oct 2025 07:39:25 GMT
 published on: 2025-10-27 19:50:03  newser.com Tue, 28 Oct 2025 00:50:03 GMT
 alphabet inc. decreases holdings in lyell immunopharma, inc. $lyel  MarketBeat Mon, 27 Oct 2025 13:33:00 GMT
 published on: 2025-10-27 03:30:07  newser.com Mon, 27 Oct 2025 08:30:07 GMT
 why ally financial inc. stock attracts strong analyst attention  newser.com Mon, 27 Oct 2025 07:16:20 GMT

Lyell Immunopharma Inc
(NASDAQ:LYEL) 

LYEL stock logo

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer. South San Francisco, California, United States.

Founded: 2018
Sector:
Industry:

Share this website to your friends